Mechanisms by which interferon (IFN)-g activates genes to promote macrophage activation are well studied, but little is known about mechanisms and functions of IFN-g-mediated gene repression. We used an integrated transcriptomic and epigenomic approach to analyze chromatin accessibility, histone modifications, transcription-factor binding, and gene expression in IFN-g-primed human macrophages. IFN-g suppressed basal expression of genes corresponding to an ''M2''-like homeostatic and reparative phenotype. IFN-g repressed genes by suppressing the function of enhancers enriched for binding by transcription factor MAF. Mechanistically, IFN-g disassembled a subset of enhancers by inducing coordinate suppression of binding by MAF, lineagedetermining transcription factors, and chromatin accessibility. Genes associated with MAF-binding enhancers were suppressed in macrophages isolated from rheumatoid-arthritis patients, revealing a disease-associated signature of IFN-g-mediated repression. These results identify enhancer inactivation and disassembly as a mechanism of IFN-gmediated gene repression and reveal that MAF regulates the macrophage enhancer landscape and is suppressed by IFN-g to augment macrophage activation.
INTRODUCTION
Interferon (IFN)-g enhances host defense and innate immune responses by activating inflammatory ''M1'' macrophages via the Jak-STAT1 signaling pathway, which induces expression of various interferon-stimulated genes (ISGs), including chemokines and antigen-presenting, antimicrobial, and antiviral molecules (Hu and Ivashkiv, 2009; Stark and Darnell, 2012) . In addition, IFN-g can prime macrophages for enhanced inflammatory responses by modulating chromatin at cis-regulatory regions of inflammatory genes (Chen and Ivashkiv, 2010) , reprogramming metabolism (Cheng et al., 2016; Su et al., 2015) , modulating mRNA translation (Su et al., 2015) , and antagonizing interleukin (IL)-4 (Piccolo et al., 2017) . In contrast to IFN-g-induced gene activation, mechanisms of IFN-g-mediated suppression of gene expression and its functional consequences are poorly understood.
Recent breakthroughs in epigenomic research have enabled the identification of enhancers, distal regulatory elements that control gene expression in a tissue-specific manner (Buecker and Wysocka, 2012) . Between 10 4 and 10 5 tissue-specific enhancers are established during development and cell differentiation by lineage-defining ''master'' or ''pioneer'' transcription factors that maintain an open chromatin environment and enable enhancer activity either constitutively or in response to environmental cues (Calo and Wysocka, 2013; Glass and Natoli, 2016) . Allelic variants associated with autoimmune disease are often found in enhancer regions, supporting the importance of enhancers in gene regulation in disease states (Bernstein et al., 2012; Farh et al., 2015; Maurano et al., 2012) . One limitation has been that enhancers have been identified mostly in cell lines or resting primary cells (Bernstein et al., 2012; Maurano et al., 2012; Okada et al., 2014) , whereas the function of a substantial proportion of immune-cell enhancers (and the allelic variants that they harbor) becomes apparent only after cell activation, including in monocytes and macrophages (Fairfax et al., 2014; Lee et al., 2014) . Thus, identification and analysis of stimulusdependent dynamic changes in enhancers is important for understanding regulation of gene expression in immune cells and the pathogenesis of immune-mediated diseases (Amit et al., 2016; Liddiard and Taylor, 2015; Shalova et al., 2015) . The macrophage enhancer repertoire, or epigenomic landscape, is determined during differentiation predominantly by the lineage-determining transcription factors (LDTFs) PU.1 and C/EBP, which open chromatin at enhancer sites (Ghisletti FCER1A  CDR2L  NMNAT3  HOMER2  KIAA1671  AKR1C3  NGFRAP1  KLHDC8B  RBP1  CD163  NPL  FCGRT  MERTK  CEBPD  VSIG4  GSTM2  F13A1  CPVL  MS4A6A  RNASE1  AP1B1  GFRA2  METTL7A  PON2  PDGFC  GPR34  ABCC5  STAB1  FOLR2  FUCA1  SEPP1  CYBRD1  LGMN  MS4A4A  SLCO2B1  LILRB5  ADORA3  EPDR1  SLC40A1  PLTP  DEPTOR  THBS1  PIK3IP1  PDK4 TPST1 TFPI
Figure 1. IFN-g Disassembles Enhancers to Suppress Gene Expression
Primary human monocytes were cultured in the absence or presence of IFN-g (100 U/ml) for 2 days.
(A) Volcano plot of transcriptomic changes between resting and IFN-g-stimulated macrophages; colored dots correspond to genes with significant (FDRadjusted p < 0.05) and greater than two-fold expression changes.
(legend continued on next page) Glass and Natoli, 2016; Natoli, 2010) . Early ideas that a stable, core enhancer repertoire determines macrophage responses to environmental stimuli have been modified by recent findings that subsets of macrophage enhancers are tissue-specific and can be induced de novo by environmental stimuli Ostuni et al., 2013) . Tissue-specific macrophage enhancers are generated by cooperation of PU.1 and/or C/EBP with various transcription factors induced by distinct tissue environmental stimuli (Gosselin et al., 2014; Lavin et al., 2014; Okabe and Medzhitov, 2014) . Tissue-specific macrophage enhancers exhibit plasticity and are remodeled upon changes in the environment in association with tissue-specific changes in expression of associated genes (Gosselin et al., 2014; Lavin et al., 2014; Okabe and Medzhitov, 2016) . Similarly, stimulation of macrophages with activating stimuli can induce de novo formation of a small number (typically < 1,000) of latent enhancers; this formation is mediated by cooperation between LDTFs and stimulus-regulated transcription factors (SRTFs). These stimulation-induced changes in enhancer landscape can be stable and are associated with epigenetic, memory-like phenomena termed ''trained immunity'' (Saeed et al., 2014) or ''short-term memory'' (Monticelli and Natoli, 2013) in innate immune cells. In contrast to the induction of enhancers, little is known about the deactivation of enhancers and associated changes in gene expression. In this study, we wished to investigate mechanisms by which IFN-g represses gene expression and the functions of such genes. We chose to examine IFN-g-mediated repression in primary human macrophages given the central role of these cells in human inflammatory diseases, including rheumatoid arthritis (RA). We used a genome-wide approach that integrated analysis of chromatin accessibility, histone modifications, transcriptionfactor binding, and gene expression. We found that IFN-g suppresses expression of genes related to an ''M2''-like homeostatic and reparative phenotype. Decreased expression of these genes was associated with deactivation of enhancers. IFN-grepressed enhancers were enriched for binding sites for the transcription factor MAF, and at a subset of these enhancers IFN-g induced a coordinate suppression of MAF binding, lineagedetermining transcription factors, and chromatin accessibility, a process we term enhancer disassembly. MAF and its M2-like target genes were suppressed in RA synovial macrophages, revealing a disease-associated signature of IFN-g-mediated repression. Thus, IFN-g disassembles enhancers to suppress expression of M2-related homeostatic and reparative genes, and MAF emerges as an important regulator of the macrophage enhancer landscape and an M2-gene-expression mediator that is targeted by IFN-g to augment macrophage activation.
RESULTS

IFN-g Decreases the Expression of Genes Involved in Homeostatic and Suppressive Functions in Human Macrophages
To analyze suppression of gene expression by IFN-g in depth, we performed RNA sequencing (RNA-seq) analysis of primary human macrophages treated with or without IFN-g for 48 hr. IFN-g induced expression of 863 genes (adjusted p < 0.05, >2-fold increase) that corresponded to a classical IFN-g signature; these genes included well-known targets of the transcription factors STAT1 and IRF ( Figure 1A ). Gene ontology (GO) and gene-set enrichment analysis (GSEA) recovered the well-known functions of IFN-g in immunity and inflammation ( Figure 1B and S1A). IFN-g suppressed the expression of 658 genes (adjusted p < 0.05, >2-fold decrease) ( Figure 1A ). Bioinformatic analysis revealed that IFN-g repressed genes with homeostatic and reparative functions related to the M2 macrophage phenotype, as well as pathways that have anti-inflammatory properties, such as apoptotic cell clearance and PPAR signaling (Figure 1B and Figure S1B) . In addition, IFN-g repressed basal expression of genes that are known to be inducible by the anti-inflammatory factors glucocorticoids (GCs) and IL-10, and to a lesser extent genes inducible by canonical M2 and ''alternative activation'' stimulus IL-4 (Xue et al., 2014) (Figure 1C ), suggesting that IFN-g counteracts the induction of these genes. These results indicate that IFN-g suppresses genes important for homeostatic M2-like macrophage functions, and they are supportive of our model (Hu and Ivashkiv, 2009 ) that inactivation of suppressive pathways by IFN-g contributes to macrophage priming or activation.
IFN-g-Mediated Repression of Target Genes Is Associated with Enhancer Disassembly
Previous work from our laboratory showed that IFN-g suppresses acetylation of histone 3 at lysine 27 (H3K27-Ac) at more than 7,000 genomic locations (Qiao et al., 2013) . H3K27-Ac marks active promoters and enhancers. We therefore tested the hypothesis that IFN-g suppresses gene expression by acting on enhancers. Following standard practice (Calo and Wysocka, 2013) , we defined enhancers as regions of open chromatin (peaks detected by ATAC-seq) that were located more than (B) Gene ontology (GO) analysis using DAVID 6.8 (Huang et al., 2009 ). (C) Heatmap showing IFN-g-repressed genes identified in (A) (rows) that are inducible by the M2-stimuli glucocorticoids, IL-10, and IL-4 on the basis of Xue et al., 2014 (columns 1-4) . (D) Representative UCSC Genome Browser tracks displaying normalized tag-density profiles at enhancers of HS3ST1, SEPP1, and CXCL10 in resting (R) and IFN-g-primed (G) macrophages. Boxes enclose non-disassembled enhancers (non-DEs, left), disassembled enhancers (DEs, middle), and latent enhancers (LEs, right) . (E) Heatmaps of H3K27ac, ATAC-seq, PU.1, and C/EBPb ChIP-seq signals at enhancers that are suppressed (upper panels) or induced (lower panels) by IFN-g. Leftmost heatmaps show all enhancers with >2-fold change in H3K27ac (see also Figure S1D ). The right three heatmaps show the subset of enhancers with >2-fold change of normalized tag counts for ATAC-seq, PU.1, and/or C/EBPb signals between resting (R) and IFN-g-primed (G) macrophages, corresponding to disassembled enhancers (DEs, top) and latent enhancers (LEs, bottom). The boxplots indicate normalized tag counts at DEs (upper right panels) and LEs (lower right panels). ****p < 0.0001, paired-samples Wilcoxon signed-rank test. Boxes encompass the 25th to 75th percentile changes. Whiskers extend to the 10th and 90th percentiles. The central horizontal bar indicates the median. Data (A-E) are representative of two biological replicates. In D-E each replicate used pooled samples from independent experiments with different donors, as described in the STAR Methods. See also Figure S1 . (legend continued on next page) 1 kb away from transcriptional start sites (TSSs) and bound macrophage lineage-determining factors PU.1 and/or C/EBP in either resting or IFN-g-stimulated macrophages as determined by ChIP-seq. This analysis identified 21,998 enhancers at which H3K27-Ac peaks were detected in primary human macrophages; these peaks showed strong concordance with DNaseseq peaks (96%, 21,044/21,998) for CD14-positive monocytes identified by the ENCODE project ( Figure S1C ). They were also concordant with the presence of histone 3 monomethylated at lysine 4 (H3K4me1, an enhancer mark) (97%, 21,293/21,998) . Out of this enhancer set, H3K27-Ac tag counts decreased by more than 2-fold after IFN-g treatment at 5,364 enhancers, increased at 5,684 enhancers, and changed less than 2-fold at 10,950 enhancers ( Figure S1D ). Genome-wide changes in the amounts of H3K27-Ac on enhancers were closely correlated with changes in IFN-g-mediated changes in the expression of associated genes ( Figure S1E ). These results suggested that IFN-g suppresses enhancer activity to decrease gene expression.
We further investigated how IFN-g deactivates enhancers. The majority (88%) of enhancers with diminished H3K27-Ac after IFN-g stimulation showed intact PU.1 and C/EBP binding and at least partially preserved open chromatin as assessed by ATAC-seq ( Figure S1F , upper panels; also Figure S1G ); gene tracks for a representative gene HS3ST1 are shown in the left panel of Figure 1D . However, a subset (12%) of these enhancers exhibited decreased ATAC-seq tag counts and decreased PU.1 and/or C/EBP binding ( Figure 1E , upper panels; gene tracks for representative gene SEPP1 are shown in Figure 1D , middle panel). Results for individual genes were confirmed by FAIRE (Figure 2G and Figure S2J ) and ChIP-qPCR assays (data not shown). As expected, in positive-control experiments IFN-g induced de novo formation of a small number of latent enhancers (Figures 1D, right panel, and 1E, bottom panels). These results suggest that IFN-g induces the loss of enhancers associated with the loss of binding by LDTFs and the closing of chromatin; hereafter we refer to these regions as ''disassembled'' enhancers (DEs). DEs showed minimally lower basal H3K27-Ac relative to nonDEs, but both enhancer types showed a comparable decrease in the amounts of H3K27-Ac after IFN-g stimulation ( Figure S1H ).
IFN-g Suppresses the Function of Enhancers Associated with M2 Genes
Functional activity of enhancers is associated with RNA polymerase II (Pol II)-mediated transcription of enhancer RNA (eRNA), interaction of enhancers with gene promoters via DNA loops, and transcription of associated genes. IFN-g suppressed eRNA expression concomitantly with suppression of mRNA transcripts in the associated gene body at representative IFN-g-inhibited genes ( Figure 2A , left panel, tracks 1 and 2). This pattern of eRNA regulation was confirmed for select genes by qPCR (data not shown). Given weak eRNA signals relative to background, we were not able to perform genome-wide eRNA analysis; instead, we used the alternative approach of measuring Pol II occupancy at enhancers by using ChIP-seq. IFN-g suppressed Pol II occupancy at disassembled enhancers while increasing Pol II occupancy at latent enhancers ( Figure 2A , tracks 5 and 6; also Figure 2B ). We obtained similar results when we analyzed only intergenic enhancers, >2 kb upstream of TSSs ( Figure S2A ). A growing body of evidence supports the idea that cohesin recruitment to active enhancers mediates looping with promoters and that cohesin occupancy can serve as a surrogate for active enhancers engaged with gene promoters (Kagey et al., 2010) . We found that IFN-g reduced occupancy of the cohesin subunit SMC1 at disassembled enhancers but increased SMC1 occupancy at induced latent enhancers ( Figures 2A and 2C) ; results at select genes were confirmed by ChIP-qPCR (data not shown). In contrast to disassembled enhancers, SMC1 occupancy was not substantially altered at the vast majority of enhancers where H3K27-Ac and Pol II signals decreased but PU.1/C/EBP binding remained intact, suggesting that significant reduction of cohesin binding is a feature of disassembled enhancers ( Figures S2B-S2D ). Collectively, the results indicated that enhancers that are disassembled after IFN-g treatment ( Figure 1E ) are functionally deactivated (Figures 2A-2C ) and suggested that expression of associated genes would be decreased by IFN-g. Indeed, the expression of genes associated with disassembled enhancers was decreased comparably to the increased expression of genes associated with IFN-ginduced latent enhancers ( Figure 2D ; gene lists are provided in Tables S1 and S2 ). Genes associated with DEs were more strongly suppressed than genes associated with non-DEs (Figure S2E) . We also found that 23% of DE genes, 7.5% of non-DE genes, and 1.9% of genes not associated with these enhancers were repressed by IFN-g, further linking the regulation of these enhancers with repression. As expected, Genomic Regions Enrichment of Annotations Tool (GREAT) and GO analysis (McLean et al., 2010) of genes associated with induced latent enhancers showed enrichment for genes involved in classic IFN-g functions, such as host defense, inflammation, and innate immunity ( Figure 2E ). In contrast, genes associated with DEs showed enrichment for homeostatic and reparative functions related to M2 phenotypes, as well as for suppressive pathways such as PPAR signaling ( Figure 2E , upper panels; also Figure S2F ). Although the mechanisms of enhancer suppression differed, non-DE genes were similarly enriched in M2-related functions ( Figure S2G ). 80% (80/100) of DE genes also were associated with a non-DE ( Figure S2H Figure S2 and Tables S1 and S2. genes by targeting more than one gene-associated enhancer by distinct mechanisms.
We next tested whether enhancer disassembly had a role in the epigenetic ''short term memory'' that maintains IFN-g-mediated gene repression or confers refractoriness to induction by suppressive stimuli. IFN-g-induced gene repression was stably maintained for at least 24-48 hr after removal of IFN-g ( Figure 2F and Figure S2I ). In accord, closing of chromatin at DEs, as assessed by FAIRE, was also stably maintained after IFN-g removal ( Figure 2G and Figure S2J ). Finally, several GC-inducible genes that were repressed by IFN-g were refractory to induction by the GC dexamethasone, even after IFN-g removal ( Figure 2H and Figure S2K ). These results provide support for the concept of ''short term memory'' in the regulation of DEassociated genes.
Promoters of Genes Repressed by IFN-g Maintain Open Chromatin
Promoters can maintain an open chromatin architecture across different cell types and activation states, whereas enhancers are more cell-type specific. Thus, we wished to compare the effects of IFN-g on enhancers and promoters of IFN-g-suppressed genes to determine whether IFN-g preferentially targets enhancers. Despite a decrease in expression ( Figure 2D) , there was only a modest change in chromatin accessibility at the promoters of genes suppressed by IFN-g via enhancer disassembly, as assessed by ATAC-seq ( Figure 3A) , and a minimal change in binding of PU.1 and C/EBPb ( Figure 3B ). Consistent with decreased gene expression, there was a modest decrease in Pol II occupancy, but the H3K27-Ac and H3K4me3 marks that are associated with open chromatin were maintained after IFN-g treatment ( Figure 3C and Figure S3A) ; H3K4me3 is present preferentially at promoters relative to enhancers. Moreover, in contrast to disassembled enhancers, SMC1 occupancy at DEassociated promoters was maintained after IFN-g stimulation ( Figure S3B ). Representative gene tracks of DE-associated promoters are shown in Figure 3D and Figure S3C . Using the same approach as described above for enhancers, we then extended our analysis to all IFN-g-repressed promoters. Out of 658 repressed genes, only three promoters satisfied the full criteria for disassembly, as defined by loss of H-Ac, LDTFs, and chromatin accessibility ( Figure 3E ). However, 9% of promoters of repressed genes met the relaxed criteria of decreased H3K27-Ac amounts and chromatin accessibility as assessed by ATAC-seq tag counts, whereas PU.1 and C/EBP binding were preserved, a category we term ''partially closed'' ( Figure 3E and 3F). Expression of genes associated with partially closed promoters was decreased as compared to that of genes that maintained promoter accessibility ( Figure S3E ); 24% (15/62) of genes associated with partially closed promoters were associated with DEs. These results are consistent with differential regulation of enhancers and promoters by IFN-g.
Identification of Candidate TFs that Regulate
Disassembled Enhancers TF repertoires change dynamically during differentiation or upon stimulation, and changes in their expression have an important role in remodeling of the enhancer landscape (Saeed et al., 2014; Tsankov et al., 2015) . In macrophages, TFs induced by environmental cues cooperate with PU.1 and C/EBP to induce de novo enhancer formation. We therefore hypothesized that IFN-g disassembles enhancers by suppressing TFs that would otherwise cooperate with PU.1 and/or C/EBP and are necessary for the formation of these enhancers. To identify candidate TFs, we combined analysis of IFN-g-induced changes in the TF repertoire of primary human macrophages with identification of TF binding motifs enriched in IFN-g-regulated enhancers. Among 72 TFs whose expression, as measured by mRNA transcripts, was changed by >2-fold upon IFN-g treatment, expression of 26 TFs decreased and that of 46 TFs increased ( Figures 4A-4C ). Motif analysis of de novo induced enhancers showed enrichment of IRF-binding motifs, consistent with a previous report in mouse macrophages (Ostuni et al., 2013) . In contrast, the MAF-binding motif was overrepresented at disassembled enhancers (p = 1 3 10 À45 ), and there was some enrichment of AP-1 and MEF2-binding motifs ( Figure 4D ). The MAF-binding motif was also overrepresented at non-DEs, which in addition showed enrichment of RUNX-binding motifs ( Figure S4A ), but not at repressed promoters ( Figure S3F ). At DEs, MAF motifs were preferentially co-enriched with both PU.1 and C/EBP motifs, whereas IRF motifs were co-enriched only at LEs ( Figure 4E ). The motif analysis, together with IFN-g-mediated decrease of MAF expression ( Figure 4A-4C ), strongly suggested that MAF plays a role in marking and possibly maintaining a subset of enhancers in resting macrophages but that this role is lost upon IFN-g stimulation. We used computational analysis of H3K27-Ac ChIP-seq data as previously described (Gosselin et al., 2014; Hnisz et al., 2013; Witte et al., 2015) to identify genes associated with IFN-g-regulated super-enhancers (SEs). SEs are clusters of active enhancers and are associated with genes important for cell identity and function. MAF was associated with a SE that harbors multiple H3K27-Ac and ATAC-seq peaks and was effectively abolished by IFN-g treatment . These results support an important functional role for MAF in macrophage biology, possibly through regulation of enhancer formation.
IFN-g Coordinately Suppresses MAF, PU.1, and C/EBP Occupancy at Disassembled Enhancers
The gene expression, binding motif, and SE analysis together suggested a role for MAF in maintaining enhancers in resting macrophages that then become disassembled when IFN-g decreases MAF occupancy. In accord with this notion, IFN-g abolished MAF occupancy at the SEPP1 DE ( Figure 5A ). ChIP-seq analysis revealed that MAF occupied the majority (77%, 492/ 642) of DEs and also the majority of non-DEs (67%, 3202/ 4722) in resting macrophages ( Figure 5B and Figure S5A ), but only bound to a much smaller fraction (6.7%) of enhancers that exhibited no change upon IFN-g treatment. Consistently, the MAF motif was enriched only at MAF-bound DEs and IFN-gregulated non-DEs ( Figure 5C and Figure S5B ). MAF was depleted from 69% (338 out of 492) of MAF-binding DE (Figure 5B ) and 62% (1,966 out of 3,172) of MAF-binding non-DEs (Figures S5A and S5C) . The peak summits of MAF, PU.1, and C/EBP binding coincided with each other and with the summits of ATAC-seq peaks, which we define as the center of an enhancer ( Figure 5D ). IFN-g induced a coordinate decrease in MAFB  ID2  CEBPD  ZFP36L1  NFXL1  MAF  ID3  EPAS1  ZNF331  TRPS1  MEF2C  ZBTB4  MXI1  CREM  KLF2  ZNF395  KDM5D  SATB1  MXD4  C20orf194  FOXP1  ZNF589  ZNF581  ZNF704  IRF4  TSHZ1   STAT1  ENO1  PLEK  NFKBIA  CEBPB  EGR2  IRF1  DRAP1  ATF3  HMGA1  MAFF  ATF5  KLF10  NR1H3  IRF9  BHLHE40  NFKB1  BCL6  MBD2  NFKBIE  ZNFX1  NFKBIB  SREBF2  PARP12  ZC3H12A  ASCL2  BHLHE41  HES4  RELB  DDB2  NFE2L3  ETV7  BATF2  SREBF1  ZNF593  MSC  MTF1  ELK1  ETV5  TCF7L2  ZNF697  KLF9  CSRNP1  VDR  NFAT5  ADNP2 
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Selected TFs associated with Repressed SEs CREM  HRH1  MAF  ANG  CRHBP  PDK4  MERTK  CABLES1  MRO  RNASE4  LPAR5  ANKH  THBS1  ASRGL1  MTSS1  ARMC9  PDGFC  ZNF704  ITGA9  STARD13 (legend on next page) MAF, PU.1, and C/EBP binding, which coincided with strongly diminished ATAC-seq tag density, indicative of the closing of chromatin ( Figure 5E ). The coincident binding in resting macrophages and coordinate loss of binding after IFN-g treatment of MAF, PU.1, and C/EBP is illustrated in gene tracks for representative SEPP1, DEPTOR, and THBS1 DEs in Figure 5F . These gene tracks also illustrate the relationship of MAF binding to H3K27-Ac, SMC1, and Pol II and the coordinate loss of these signals after IFN-g treatment. Together, our findings suggest that at DEs, IFN-g reduced MAF binding and contributed to concomitant destabilization of PU.1 and C/EBP binding, a decrease of chromatin accessibility, and a loss of enhancer function at disassembled enhancers. In contrast to MAF, DEs bound low amounts of STAT1 and IRF1, transcription factors that bind directly to enhancers and LEs in response to IFN-g (Ostuni et al., 2013) (Qiao et al., 2013) ; STAT1 and IRF1 occupancy minimally increased at DEs after IFN-g stimulation ( Figures S5D-S5E ). These results argue against a direct regulation of DEs by STAT1 and support an indirect mechanism of IFN-g action via suppression of MAF and possibly other IFN-g-repressed TFs. Thus, the mechanisms of induction of latent enhancers and suppression of DEs are distinct.
Regulation of IFN-g-Suppressed M2-like Genes by MAF
To directly implicate MAF in the regulation of IFN-g-suppressed M2-like genes, we combined a loss-of-function approach involving RNA interference (RNAi) with a gain-of-function approach involving forced expression. RNAi of MAF in primary human macrophages decreased expression of several DE-associated and other M2-like genes ( Figure 6A ; Figures S6A and  S6B) . RNA-seq analysis identified 138 genes, including MAFbinding DE genes, whose expression was dependent on MAF in a non-redundant manner ( Figures 6B and 6C) . RNAi of MAF decreased the expression of IFN-g-repressed genes but not that of genes insensitive to IFN-g regulation; the expression of genes associated with DEs was more significantly decreased upon MAF RNAi than was that of genes linked with non-disassembled enhancers or other IFN-g-repressed genes ( Figure 6D ; Figures S6C and S6D ). In addition, expression of MAF-bound, DE-associated genes was more strongly suppressed than that of MAF-bound, non-DE-associated genes ( Figure S6D , right panel). These data suggest that MAF plays a non-redundant role in the expression of a subset of IFN-g-repressed genes and that it is largely dedicated to the expression of genes that are susceptible to repression.
We next tested whether the loss of MAF could contribute to disassembly of enhancers. MAF RNAi decreased chromatin accessibility at 15 out of 24 DEs that were tested by FAIRE assays ( Figure 6E ; Figure S6E ). These results suggest that MAF plays a role in maintaining chromatin accessibility at a subset of DEs but that it is redundant at other DEs, where additional transcription factors that are decreased by IFN-g might play a role.
We analyzed gene expression when MAF expression was reconstituted in IFN-g-treated macrophages by using adenoviral transduction. Ectopic MAF expression prevented the decrease in expression of a subset of IFN-g-repressed genes ( Figure 6F and Figure S6F ). RNA-seq analysis showed that MAF significantly prevented IFN-g-mediated repression of 228 genes, which included genes associated with as well as genes not associated with DEs ( Figures 6G-6I and Figures S6G and S6H ). Ectopic expression of MAF had a larger impact on the expression of IFN-g-repressed genes than on that of non-repressed genes and a larger impact on the expression of genes associated with DEs than on that of non-DE genes, supporting selectivity of MAF function on genes repressed by IFN-g ( Figure 6I and Figure S6H ). ImmuNet analysis (Gorenshteyn et al., 2015) revealed that MAF was functionally connected to DE-associated genes and other IFN-g-suppressed genes characteristic of the M2 macrophage phenotype ( Figure S6J ). In accord with the geneexpression results, ectopic MAF expression nearly completely reversed IFN-g-mediated closing of chromatin at 10 out of 18 enhancers tested and had partial effects at the other eight (Figure 6J and Figure S6I ). Collectively, these results suggest that MAF expression is sufficient to maintain open chromatin and prevent repression of a subset of IFN-g-repressed genes, especially those associated with DEs.
Low MAF Expression and a ''Negative IFN-g Signature'' in RA Synovial Macrophages An ''IFN-g signature'' consisting of elevated expression of STAT1 target genes has been linked with pathogenesis of several autoimmune diseases, including RA, and is observed upon gene expression analyses of RA synovial (joint) tissue and macrophages (Hu et al., 2008) . We wished to test whether a gene expression signature corresponding to IFN-g-mediated suppression of transcription is also present in RA synovial macrophages. We used GSEA of transcriptomic data to compare RA synovial (Donlin et al., 2014 ) (GSE97779) and control macrophages. As expected, expression of IFN-g-induced genes was increased in RA synovial macrophages relative to control macrophages ( Figure 7A, top panel) . The expression of IFN-grepressed genes was decreased in RA synovial macrophages relative to control macrophages ( Figure 7A , bottom panel), which we term a ''negative IFN-g signature.'' RA synovial macrophages showed significantly lower amounts of MAF mRNA and higher amounts of STAT1 and IRF1 transcripts than did control macrophages ( Figure 7B ). This result prompted us to analyze RA synovial macrophage expression of DE-associated genes (marked by MAF) and LE-associated genes (marked by STAT1 and IRF1). The expression of 83% (58/70) of DE-associated genes was decreased in RA synovial macrophages relative to control macrophages, whereas the expression of 92% (73/79) of LEassociated genes was increased in RA synovial macrophages ( Figure 7C ). Representative DE-and LE-associated genes differentially expressed in RA synovial macrophages are displayed in the heatmaps in Figure 7D . These findings support the pathophysiological relevance of IFN-g-mediated suppression of MAF and downstream gene expression.
DISCUSSION
Although it has been long known that IFN-g broadly suppresses gene expression in macrophages (Ehrt et al., 2001) , the functions of IFN-g-repressed genes and mechanisms of repression are mostly unknown. Our study reveals that in parallel to the wellknown induction of immune genes, IFN-g also suppresses genes with homeostatic, reparative, and anti-inflammatory functions. Whereas repression of these genes can augment host defense and sustain inflammation, it might also prevent the resolution of inflammation and contribute to aberrant tissue remodeling and repair in chronic inflammatory diseases such as RA (McInnes and Schett 2011). Our findings identify inactivation and disassembly of enhancers as a mechanism by which IFN-g suppresses gene expression. IFN-g accomplishes this disassembly by suppressing expression and binding of MAF to a subset of IFN-gregulated enhancers, thereby contributing to the concomitant loss of LDTFs and chromatin accessibility. MAF is an important M2-gene regulator that is suppressed during RA and functions at least in part by maintaining enhancer function. These results provide insight into mechanisms and functional consequences of IFN-g-mediated gene repression in macrophages.
Although enhancer formation and activation have been extensively studied, less is known about mechanisms of enhancer deactivation. Previous work mostly performed in non-immune cell types has highlighted active repressive mechanisms whereby transcriptional repressors recruit corepressor complexes that contain enzymes that diminish enhancer activity by removing positive histone marks or by depositing negative histone marks (Perissi et al., 2010; Whyte et al., 2012) (Lam et al., 2013) . In contrast, we found that repression of enhancers by IFN-g was mediated by loss of a key enhancerbinding transcription factor, MAF, which is accompanied by decreased LDTF binding, closing of chromatin, and enhancer disassembly. In contrast to histone-mark changes that are readily and quickly reversible, re-assembly of an enhancer would take longer because it would require synthesis of the relevant transcription factor(s), such as MAF, and remodeling of closed chromatin (Buecker et al., 2014; Heinz et al., 2015) . In accord with this notion, we found that IFN-g-mediated repression of DE genes was stable and resistant to induction by glucocorticoids. This is consistent with a concept of ''short term memory,'' whereby loss of enhancers that mediate gene induction by macrophage-deactivating stimuli, such as IL-10, IL-4, and glucocorticoids, can result in refractoriness of genes to induction by these M2 stimuli and may affect macrophage polarization states.
Disassembly of enhancers can account for suppression of approximately 15% of the 658 genes that were downregulated by IFN-g, indicating that additional mechanisms contribute to IFN-g-mediated gene repression. One such mechanism might be related to downregulation of histone acetylation at non-disassembled enhancers, which occurred broadly at more than 5,000 enhancers and was associated with decreased gene expression. IFN-g-induced deacetylation of enhancers could be mediated by recruitment of HDAC-containing corepressor complexes, but initial ChIP-qPCR experiments have not detected recruitment of corepressors (data not shown). Another possibility is that IFN-g induces deposition of negative histone marks. However, genome-wide analysis revealed very limited targeting of promoters (Qiao et al., 2016) , but not enhancers, by the negative mark H2K27me3 and no clear changes in H3K9me3 after IFN-g treatment. Overall, our findings identify one mechanism by which IFN-g represses functionally important genes and open lines of investigation into mechanisms of target gene repression by IFNs and cytokines that utilize the Jak-STAT signaling pathway.
MAF has a well-established role in adaptive immunity, where it promotes the differentiation and function of Th2, Tr1, and T FH cells, as well as the expression of type 2 and suppressive cytokines (Apetoh et al., 2010; Liu et al., 2013; Pot et al., 2011 ) (Cao et al., 2005 Liu et al., 2013; Pot et al., 2011) . In embryonic stem cells and mouse macrophages, MAF (together with related MAFB) suppress expression of self-renewal genes (Aziz et al., 2009; Soucie et al., 2016) . Our findings indicate that MAF has a distinct function and mechanism of action, namely binding to and maintaining the activity of a unique subset of macrophage enhancers and thereby promoting the expression of a subset of M2 genes. This M2-like function of MAF in macrophages is consonant with its function in promoting IL-4 and IL-10 expression in T cells and with a previous report implicating MAF in Il10 induction in mouse macrophages (Cao et al., 2002) . This finding is also in line with a recent report that the MAF motif is enriched in a panel of IL-4-induced enhancers that were sensitive to inhibition by IFN-g (Piccolo et al., 2017) . Notably, MAF binding was most closely associated with enhancers that were disassembled after IFN-g stimulation, and thus MAF occupancy can serve as a ''mark'' for enhancers that are targeted by IFN-g. Overall, our findings indicate a key and non-redundant role for MAF in a subset of IFN-g-regulated genes and implicate downregulation of MAF as an important component of the IFN-g response in human macrophages. SEPP1  ARMC9  CRHBP  FBLIM1  TMEM37  FUCA1  KLHL13  ZNF704  CNRIP1  ASRGL1  PDK4  EEPD1  DAB2  MRO  ITSN1  KIF26B  CABLES1  CELSR1  MMD  GPR34  STARD13  SMS  BMP2  PSCA  KIAA1147  SLMO1  ZADH2  MGAT5  C22orf29  PIK3IP1  DCBLD1  LGMN  B3GNT2  ZC3H12D  NTAN1  PDGFC  PEX11G  THADA  XYLT1  APMAP  CRYL1  TESK2  LY86  C20orf194  AP1B1  PPM1L  MAF  NISCH  SGPL1  PTGFRN  DEPTOR  SOCS6  PMP22  MGAT4A  TRPS1  ADCY9  SWAP70  LPAR6   Control Rheumatoid arthritis   FLT1  APOBEC3A  GBP5  MGAM  CXCL11  CXCL10  P2RY14  FAM26F  NEDD9  MYOF  EGR3  GCH1  SERPINA1  IL1RN  PDE4B  PRKAR2B  CCND2  SPATA13  CD80  HSD11B1  MGC12916  TNFSF10  FBP1  ISG20  IL15  KREMEN1  GLIPR2  NFE2L3  LCP2  KLF9  BCL2A1  JAK2  STX11  BCL6  NLRC5  ASAP2  SNX10  TAGAP  MX1  SOD2  HIVEP2  RHBDF2  UBE2L6  P2RX7  SEMA4D  ZCCHC2  ANKRD33B  ARHGEF3  GK  PCNX  SH2B2  F3  CD226  CD274  EXT1  CDK14  LYSMD2  KLF10  TANK  RMI2  IRG1  C4orf32  SLC31A2  MREG  GPC4  LMTK2  RASSF5  NMI  LYN  TGM2  TRIB2 PTPN6 NFKBIA However, transcriptomic analysis of macrophages in which MAF was silenced or ectopically expressed made clear that MAF is redundant for maintaining gene expression and open chromatin at distinct subsets of IFN-g-repressed genes. It is likely that other transcription factors whose expression is maintained in IFN-g-stimulated macrophages are sufficient to promote enhancer accessibility and expression of these genes. The transcriptomic results, together with analysis of DEs, nonDEs, promoters, and MAF ChIP-seq suggest a complex model for MAF function in human macrophages: (1) MAF plays a nonredundant role in maintaining open chromatin and gene expression in a subset of DEs and IFN-g-repressed genes, (2) MAF promotes expression of other DE and non-DE genes but is redundant for maintaining open chromatin, and (3) MAF is functionally linked to IFN-g-repressed enhancers and associated genes and has little role in expression of non-repressed genes or genes not regulated by IFN-g. Although MAF is linked to IFN-g-mediated repression in human macrophages, it regulates only a subset of IFN-g-repressed genes and functions in the context of a complex IFN-g-induced gene expression program that modulates expression of multiple transcription factors. In other cell types, MAF cooperates with various transcription factors, including AhR, Blimp1, Bcl6, Id2, IRF4, KLFs, and MAFB, to regulate target gene expression. Interestingly, some of these and closely related transcription factors, namely Id2, Id3, IRF4, KLF2, and MAFB, were co-regulated with MAF after IFN-g stimulation. This suggests that IFN-g might downregulate a network of functionally related transcription factors that cooperate to promote expression of genes that are repressed by IFN-g.
In summary, our study provides insights into the functional consequences of IFN-g-induced gene repression and into underlying mechanisms that suppress the function and induce the loss of a subset of the constitutive enhancer repertoire in human macrophages. These findings have implications for our understanding of how gene expression is regulated in IFN-g-driven immune responses and diseases states and how it can potentially be therapeutically modulated. This work opens avenues of investigation into the poorly understood mechanisms by which cytokines repress gene expression.
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by IFN-g were defined as expressed genes with p-value adjusted for multiple testing (FDR < 0.05) and log 2 fold-change of at least 1. For Figure 6 and S6, significantly down-or upregulated genes were selected based on log 2 fold-change of at least 0.3 and p-value < 0.05.
Gene Ontology Analysis
To find the GO terms enriched in IFN-g differentially regulated genes, we used the DAVID web-tool (Huang et al., 2009 ).
Chromatin Immunoprecipitation
Cells were crosslinked for 5 min at room temperature by the addition of one-tenth of the volume of 11% formaldehyde solution (11% formaldehyde, 50 mM HEPES pH 7.5, 100 mM NaCl, 1 mM EDTA pH 8.0, 0.5 mM EGTA pH 8.0) to the growth media followed by 5 min quenching with 100 mM glycine. Cells were pelleted at 4 C and washed with ice-cold PBS. The crosslinked cells were lysed with lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, and 0.25% Triton X-100) with protease inhibitors on ice for 10 min and washed with washing buffer (10 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA) for 10 min. The lysis samples were resuspended and sonicated in sonication buffer (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine) using a Bioruptor (Diagenode) with 30 s ON, 30 s OFF on high power output for 18 cycles. After sonication, samples were centrifuged at 14,000 rpm for 10 min at 4 C and 5% of sonicated cell extracts were saved as input. The resulting whole-cell extract was incubated with Protein A Agarose for ChIP (EMD Millipore) for 1 hr at 4 C. Precleared extracts were then incubated with 50 mL (50% v/v) of Protein A Agarose for ChIP (EMD Millipore) with 5 mg of the appropriate antibody overnight at 4 C. PU.1, C/EBPb, MAF, RNA Polymerase II and SMC1 ChIP lysates were generated from 2 3 10 7 cells, 3 3 10 7 cells, 4 3 10 7 cells, 2 3 10 7 cells, and 10 3 10 7 cells respectively. ChIP antibodies against PU.1 (sc-352), C/EBPb (sc-150),
and MAF (sc-7866) were from Santa Cruz Biotechnology. Antibodies against RNA Polymerase II (MMS-126R) were from Covance. Antibodies against SMC1 (A300-055A) were from Bethyl Laboratories. After overnight incubation, beads were washed twice with sonication buffer, once with sonication buffer with 500 mM NaCl, once with LiCl wash buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 250 mM LiCl, 1% NP-40), and once with TE with 50 mM NaCl. DNA was eluted in freshly prepared elution buffer (1% SDS, 0.1M NaHCO 3 ). Cross-links were reversed by overnight incubation at 65 C. RNA and protein were digested using RNase A and Proteinase K, respectively and DNA was purified with ChIP DNA Clean & Concentrator (Zymo Research). For ChIP assays, immunoprecipitated DNA was analyzed by quantitative real-time PCR and normalized relative to input DNA amount.
ChIP-Seq Library Preparation and Sequencing
For ChIP-seq experiments, 10 ng of purified ChIP DNA per sample were ligated with adaptors and 100-300 bp DNA fragments were purified to prepare DNA libraries using Illumina TruSeq ChIP Library Prep Kit following the manufacturer's instructions. ChIP libraries were sequenced (50 bp single end reads) using an Illumina HiSeq 2500 Sequencer at the Epigenomic Core Facility of Weill Cornell Medicine per manufacturer's recommended protocol.
Because of limitations on cell numbers and to decrease variability related to differences among individual donors, chromatin immunoprecipitations were performed using pooled samples from at least two different donors. For PU.1, C/EBPb, and SMC1, a second experiment with pooled samples from several donors was performed and congruence between the replicates was assessed by generating scatterplots and estimating Pearson correlation coefficients ( Figure S1I and S1J). After ascertaining close correlation between replicates, we performed bioinformatic analysis using replicate 1 and confirmed key results using replicate 2. The H3K27ac, STAT1 and IRF1 data were from GSE43036.
Assay for Transposase-Accessible Chromatin using Sequencing ATAC-seq was performed as previously described (Buenrostro et al., 2013) . Briefly, 50,000 cells were centrifuged 500 g for 5 min at 4 C. Cell pellets were washed once with 1x PBS and cells were pelleted by centrifugation using the previous settings. Cell pellets were resuspended in 25 mL of lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.1% IGEPAL CA-630) and centrifuged immediately 500 g for 10 min at 4 C. The cell pellet was resuspended in the transposase reaction mix (25 mL 2 3 TD buffer (Nextera DNA Sample Preparation Kit), 2.5 mL Illumina Tn5 transposase and 22.5 mL nuclease-free water). The transposition reaction was carried out for 30 min at 37 C. Directly following transposition, the sample was purified using a QIAGEN MinElute Purification Kit. Then, we amplified library fragments using NEBNext 2x PCR master mix and 1.25 M Nextera PCR primers, using the following PCR conditions: 72 C for 5 min; 98 C for 30 s; and thermocycling at 98 C for 10 s, 63 C for 30 s and 72 C for 1 min. The libraries were purified using a QIAGEN PCR purification kit yielding a final library concentration of $30 nM in 20 mL. Libraries were amplified for a total of 10-13 cycles and were subjected to high-throughput sequencing using the Illumina HiSeq 2500 Sequencer.
ChIP-seq and ATAC-seq Analysis For ChIP-seq and ATAC-seq experiments, sequenced reads were aligned to reference human genome (GRCh37/hg19 assembly) using Bowtie2 version 2.2.6 (Langmead and Salzberg, 2012) with default parameters, and clonal reads were removed from further analysis. A minimum of 10 million uniquely mapped reads were obtained for each condition. We used the makeTagDirectory followed by findPeaks command from HOMER version 4.7.2 (Heinz et al., 2010) to identify peaks of ChIP-seq enrichment over background. A false discovery rate (FDR) threshold of 0.001 was used for all datasets. The total number of mapped reads in each sample was normalized to ten million mapped reads. ChIP-seq data were visualized by preparing custom tracks for the UCSC Genome browser.
